REGENXBIO INC (RGNX)

US75901B1070 - Common Stock

7.725  +0.1 (+1.38%)

Buy % Consensus

84

ChartMill assigns a Buy % Consensus number of 84% to RGNX. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 36.72. This target is 375.34% above the current price.
RGNX was analyzed by 19 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about RGNX.
In the previous month the buy percentage consensus was at a similar level.
RGNX was analyzed by 19 analysts, which is quite many. So the average rating should be quite meaningful.

Price Target & Forecast

Price Low Median Mean High 7.7318.1838.7636.7254.60 - 135.34% 401.75% 375.34% 606.80%
Up and Down Grades
Date Firm Action Rating
2024-12-11 RBC Capital Reiterate Outperform -> Outperform
2024-11-21 HC Wainwright & Co. Maintains Buy -> Buy
2024-11-20 Chardan Capital Maintains Buy -> Buy
2024-11-07 HC Wainwright & Co. Maintains Buy -> Buy
2024-10-22 Chardan Capital Maintains Buy -> Buy
2024-10-10 Raymond James Reiterate Outperform
2024-09-04 HC Wainwright & Co. Reiterate Buy -> Buy
2024-08-05 Barclays Maintains Overweight -> Overweight
2024-08-05 HC Wainwright & Co. Maintains Buy -> Buy
2024-06-20 HC Wainwright & Co. Reiterate Buy -> Buy
2024-06-07 Goldman Sachs Initiate Buy
2024-05-15 HC Wainwright & Co. Maintains Buy -> Buy
2024-04-12 Stifel Maintains Buy -> Buy
2024-03-11 HC Wainwright & Co. Initiate Buy
2024-03-08 RBC Capital Upgrade Sector Perform -> Outperform
2024-03-07 Chardan Capital Maintains Buy -> Buy
2024-03-07 Barclays Maintains Overweight -> Overweight
2024-03-06 Leerink Partners Upgrade Market Perform -> Outperform
2024-03-06 Baird Maintains Outperform -> Outperform
2024-02-28 Wedbush Reiterate Neutral -> Neutral
2024-02-21 Raymond James Reiterate Outperform
2024-02-12 Wedbush Reiterate Neutral -> Neutral
2023-11-01 Stifel Initiate Buy
2023-10-05 Wedbush Reiterate Neutral -> Neutral
2023-10-04 RBC Capital Reiterate Sector Perform -> Sector Perform
2023-08-29 Morgan Stanley Maintains Overweight -> Overweight
2023-08-03 Chardan Capital Reiterate Buy
2023-07-12 RBC Capital Reiterate Sector Perform -> Sector Perform
2023-06-20 Baird Initiate Outperform
2023-06-02 Baird Initiate Outperform